Mysterious Company Drops Patent Challenge To Sanofi-Aventis' Plavix

Law360, New York (August 5, 2005, 12:00 AM EDT) -- An obscure Scottish company that had filed a mysterious challenge to the U.K. patent covering Sanofi-Aventis’ best-selling blood thinner Plavix has dropped its lawsuit, Sanofi-Aventis said Friday.

“Today Sanofi-Aventis announced that Aircoat has withdrawn the revocation action by which it had sought to invalidate the Sanofi-Aventis patent in the U.K.,” Sanofi said in a statement.

Aircoat, which is based in Scotland, started legal proceedings against Sanofi-Aventis in January this year in an attempt to overturn the patent for clopidogrel bisulfate, the main ingredient in its Plavix...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.